To justify, Kahlert et al. revealed that ALDH1A1 expression was not significantly connected with prognosis in CRC and did not predict response to chemotherapy in patients with metastatic diseases [52]. This evidence concerns the gene ALDH1A1 and colorectal carcinoma.